Praveen P. Tipirneni - Jan 14, 2022 Form 4 Insider Report for Morphic Holding, Inc. (MORF)

Role
President and CEO, Director
Signature
/s/ Robert Farrell as attorney-in-fact for Praveen P. Tipirneni
Stock symbol
MORF
Transactions as of
Jan 14, 2022
Transactions value $
$0
Form type
4
Date filed
1/19/2022, 06:14 PM
Next filing
Jan 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MORF Common Stock 4.21K Jan 14, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MORF Stock Option (right to buy Common Stock) Award $0 +224K $0.00 224K Jan 14, 2022 Common Stock 224K $44.75 Direct F2
transaction MORF Restricted Stock Units (RSU) Award $0 +50K $0.00 50K Jan 14, 2022 Common Stock 50K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 920 shares of Common Stock acquired under the issuer's employee stock purchase plan on February 26, 2021.
F2 The option vests as to 2.0833% of the total shares monthly, beginning February 14, 2022, with 100% of the total shares vested and exercisable on January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.
F3 Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
F4 The RSUs vest as to 25% of the total shares on each of January 14, 2023, January 14, 2024, January 14, 2025, and January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.